EUROPEAN SOCIETY FOR CLINICAL VIROLOGY
Promote public health and advance public medical education by: Improving knowledge of viruses, especially diagnosis and management of viral diseases, pathogenesis, natural history and prevention; Improving diagnostic methods; Promoting high standards in laboratory viral diagnosis through quality assessment activities, education and development of reference standards.
Objects
THE CHARITY'S OBJECTS ARE TO PROMOTE PUBLIC HEALTH AND TO ADVANCE PUBLIC EDUCATION, IN PARTICULAR MEDICAL EDUCATION, BY:(1) IMPROVING THE KNOWLEDGE OF VIRUSES, PARTICULARLY AS IT RELATES TO THE DIAGNOSIS AND MANAGEMENT OF VIRAL DISEASES, THEIR PATHOGENESIS, NATURAL HISTORY AND PREVENTION;(2) IMPROVING DIAGNOSTIC METHODS;(3) PROMOTING HIGH STANDARDS IN LABORATORY VIRAL DIAGNOSIS THROUGH QUALITY ASSESSMENT ACTIVITIES AND EDUCATION; AND(4) PROMOTING OR DEVELOPING PREPARATION AND EXCHANGE OF REFERENCE REAGENTS.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net loss of £117,868 for the year ended 31 October 2025. Free reserves decreased from £27,466 to £47,296 (converted from EUR 53,759), though the document notes a foreign exchange conversion impact. The filing admits to an audit exemption under the small companies regime.
What the accounts disclose
“The Executive has the policy to maintain sufficient funds to allow the Society to meet its objectives and obligations on a long-term basis, and to provide a measure of investment income.” — page 4
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/10/2025
- Trustee benefits, answered Yes to: any trustee benefit; other trustee benefit
Self-declared on the annual return for the financial year ending 31/10/2024
- Volunteers: 4
Trustees
- Dr Annelies Riezebos-Brilman
- Dr Catherine Moore
- Dr Heli Harvala
- Dr Mario Hoenemann
- Dr Xavier Lopez Labrador
- Professor George Sourvinos
- Professor Jerome Le Goff
- Professor Pamela Josephine Vallely
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/10/2025 | £62k | £43k |
| 31/10/2024 | £61k | £178k |
| 31/10/2023 | £73k | £199k |
| 31/10/2022 | £106k | £57k |
| 31/10/2021 | £22k | £53k |
Common questions
Is EUROPEAN SOCIETY FOR CLINICAL VIROLOGY financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net loss of £117,868 for the year ended 31 October 2025. Free reserves decreased from £27,466 to £47,296 (converted from EUR 53,759), though the document notes a foreign exchange conversion impact. The filing admits to an audit exemption under the small companies regime.
Charities like this
- CLINICAL VIROLOGY NETWORK
- EUROPEAN SOCIETY FOR VASCULAR SURGERY
- THE VASCULAR SOCIETY
- EUROPEAN FOUNDATION FOR VETERINARY DENTISTRY
- THE EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY
- CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION)
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| EUROPEAN SOCIETY FOR CLINICAL VIROLOGY | £62k | — | 0 | unclear | — | no doubt |
| CLINICAL VIROLOGY NETWORK | £50k | — | 0 | unclear | — | no doubt |
| EUROPEAN SOCIETY FOR VASCULAR SURGERY | £3.4m | more than €70,000 | 1 | unclear | — | no doubt |
| THE VASCULAR SOCIETY | £590k | — | 0 | unclear | — | no doubt |
| EUROPEAN FOUNDATION FOR VETERINARY DENTISTRY | £30k | — | — | unclear | — | no doubt |
| THE EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY | £6.1m | — | — | unclear | — | no doubt |